Elevation in Tanis Expression Alters Glucose Metabolism and Insulin Sensitivity in H4IIE Cells
- Yuan Gao1,
- Ken Walder1,
- Terry Sunderland1,
- Lakshmi Kantham1,
- Helen C. Feng1,
- Melissa Quick1,
- Natalie Bishara1,
- Andrea de Silva1,
- Guy Augert2,
- Janette Tenne-Brown1 and
- Gregory R. Collier1
- 1Metabolic Research Unit, School of Health Sciences, Deakin University, Victoria, Australia
- 2Merck Santé, Lyon, France
Abstract
Increased hepatic glucose output and decreased glucose utilization are implicated in the development of type 2 diabetes. We previously reported that the expression of a novel gene, Tanis, was upregulated in the liver during fasting in the obese/diabetic animal model Psammomys obesus. Here, we have further studied the protein and its function. Cell fractionation indicated that Tanis was localized in the plasma membrane and microsomes but not in the nucleus, mitochondria, or soluble protein fraction. Consistent with previous gene expression data, hepatic Tanis protein levels increased more significantly in diabetic P. obesus than in nondiabetic controls after fasting. We used a recombinant adenovirus to increase Tanis expression in hepatoma H4IIE cells and investigated its role in metabolism. Tanis overexpression reduced glucose uptake, basal and insulin-stimulated glycogen synthesis, and glycogen content and attenuated the suppression of PEPCK gene expression by insulin, but it did not affect insulin-stimulated insulin receptor phosphorylation or triglyceride synthesis. These results suggest that Tanis may be involved in the regulation of glucose metabolism, and increased expression of Tanis could contribute to insulin resistance in the liver.
Footnotes
-
Address correspondence and reprint requests to Yuan Gao, Metabolic Research Unit, School of Health Sciences, Deakin University, Pigdons Road, Victoria 3217, Australia. E-mail: gao{at}deakin.edu.au.
Received for publication 22 August 2002 and accepted in revised form 7 January 2003.
Ad, adenovirus; DMEM, Dulbecco’s modified Eagle’s medium; GFP, green fluorescence protein; HDM, high-density microsomes; IR, insulin receptor; IRS, IR substrate; LDM, low-density microsome; M/N, mitochondria/nucleus; MOI, multiplicity of infection; PM, plasma membrane; SAA-1β, serum amyloid A-1β.
- DIABETES











